Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Event-Driven

<ul>
<li>On 8 April, the Korea Exchange announced special changes to KOSDAQ 150. NKMAX will be excluded from KOSDAQ 150 and it will be replaced by GI Innovation.</li>
<li>NKMAX was designated as "administrative issue" and "investment attention issue" on 8 April 2024, which resulted in the Korea Exchange deciding to remove this stock from KOSDAQ 150. </li>
<li>We believe that this inclusion of GI Innovation in KOSDAQ 150 is likely to further positively impact its share price.</li>
</ul>


On 8 April, the Korea Exchange announced special changes to KOSDAQ 150. NKMAX will be excluded from KOSDAQ 150 and it will be replaced by GI Innovation.
NKMAX was designated as "administrative issue" and "investment attention issue" on 8 April 2024, which resulted in the Korea Exchange deciding to remove this stock from KOSDAQ 150. 
We believe that this inclusion of GI Innovation in KOSDAQ 150 is likely to further positively impact its share price.


Special Changes in KOSDAQ 150: Deletion (NKMAX) + Addition (GI Innovation)

South Korea

GI Innovation, Inc. operates as a bio-venture company. The Company provides biologics products development, production, and marketing services. GI Innovation markets its products throughout Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

GI Innovation (358570 KS)

Special Changes in KOSDAQ 150: Deletion (NKMAX) + Addition (GI Innovation)

On 8 April, the Korea Exchange announced special changes to KOSDAQ 150. NKMAX will be excluded from KOSDAQ 150 and it will be replaced by GI...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)